Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 03, 2015 5:01 PM ET

Pharmaceuticals

Company Overview of Chugai Pharmaceutical Co. Ltd.

Executive Profile

Hisashi Hara

Outside Audit & Supervisory Board Member, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
67--

Background

Mr. Hisashi Hara serves as the Chairman of Nagashima Ohno & Tsunematsu. Mr. Hara serves Director of Everglory Group Limited since March 2014. His principal practice areas include a variety of transnational and domestic transactions with emphasis on real estate acquisition, development, financing and securitization, M&A, joint ventures and corporate restructuring. Mr. Hara became a partner in 1983. In 1991, he became managing partner of Nagashima & Ohno, and in 2000, ...

Corporate Headquarters

1-1 Nihonbashi-Muromachi 2-Chome
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships

Chairman
2014-Present
Director

Education

LLB 1972
Tokyo University of Science
Master's Degree 1980
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
$6.6M
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chugai Pharmaceutical Co. Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.